We are live on
!
Find out more
Neurocrine Biosciences
NBIX
NBIX
694 hedge funds and large institutions have $13.1B invested in Neurocrine Biosciences in 2026 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 302 increasing their positions, 216 reducing their positions, and 109 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
24% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 109
43% less call options, than puts
Call options by funds: $39.1M | Put options by funds: $69M
Holders
694
Holding in Top 10
8
Calls
$39.1M
Puts
$69M
Top Buyers
| 1 | +$275M | |
| 2 | +$221M | |
| 3 | +$166M | |
| 4 |
Millennium Management
New York
|
+$107M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$80.5M |
Top Sellers
| 1 | -$228M | |
| 2 | -$225M | |
| 3 | -$152M | |
| 4 |
DM
Deerfield Management
New York
|
-$76.2M |
| 5 |
ZIG
Zurich Insurance Group
Zurich,
Switzerland
|
-$65.2M |
